Okklo Life Sciences
Okklo life sciences BV is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies. The current programs are focussed on lysosomal storage disorders and cardiovascular disorders. The company was founded in December 2011 by a group of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin marketed as a drug product. We are continuously looking for collaborations and partnering opportunities with public and private partners - please visit our website to learn more about our technology platform strategy and development pipeline.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Okklo Life Sciences
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Okklo Life Sciences
2 distinct titles indexed · top 2 shown.
- 1chief scientific officer
- 1öğrenci
Sign up to unlock all 2 contacts at Okklo Life Sciences
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Okklo Life Sciences
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.